Skip to main content
Be The Investor
Home›Stocks›ARQT

Arcutis Biotherapeutics, Inc.

ARQT
NASDAQUnited States flagUSReal-Time Price
$28.38USD
+0.99 (+3.63%)Today
$26.20-2.18 (-7.68%)After HoursLast quote · Nov 9, 2026, 4:06 PM ET · Updates paused

Investors Sentoments

Sign in to share your view.

BTI Score

BASIC required or higher

View pricing
BTI Fair Market Cap
$1.63B
+120.63% vs fair
Biotechnology
High Risk

Arcutis Biotherapeutics, Inc. (ARQT) Forecast & Price Targets

Review available Arcutis Biotherapeutics, Inc. (ARQT) analyst price targets and compare them with earnings and valuation. Analyst targets are separate from BTI scores; missing data is marked unavailable.

ARQT stock forecast and analyst price targets

Analyst price targets estimate possible future share prices. They are separate from BTI scores and fair-value models. The highest and lowest targets describe the provider's range, not the probability of a bull or bear scenario.

ARQT targets — Financial Modeling Prep — price-target-consensus. Target publication dates and investment horizons are not supplied by this feed.
MeasureTarget (USD)Difference from available quote
Highest analyst target48.00+69.1%
Consensus analyst target41.80+47.3%
Lowest analyst target38.00+33.9%

The comparison uses the available quote, which may be delayed. It is not an expected return over a specified period.

How should I evaluate the ARQT forecast?

Compare the targets with reported earnings, cash flow, valuation assumptions and company risks. A price target alone does not determine whether an investment is suitable.